| Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells T Saha, C Dash, R Jayabalan, S Khiste, A Kulkarni, K Kurmi, J Mondal, ... Nature nanotechnology 17 (1), 98-106, 2022 | 167 | 2022 |
| An N6-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells MB Uddin, KR Roy, SB Hosain, SK Khiste, RA Hill, SD Jois, Y Zhao, ... Biochemical pharmacology 160, 134-145, 2019 | 82 | 2019 |
| Inhalable lactoferrin–chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma MM Abd Elwakil, MT Mabrouk, MW Helmy, EZA Abdelfattah, SK Khiste, ... Nanomedicine 13 (16), 2015-2035, 2018 | 75 | 2018 |
| Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance A Goldman, S Khiste, E Freinkman, A Dhawan, B Majumder, J Mondal, ... Science signaling 12 (595), eaas8779, 2019 | 58 | 2019 |
| Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer … SB Hosain, SK Khiste, MB Uddin, V Vorubindi, C Ingram, S Zhang, RA Hill, ... Oncotarget 7 (37), 60575, 2016 | 47 | 2016 |
| Protein-polysaccharide nanohybrids: Hybridization techniques and drug delivery applications M Gaber, MT Mabrouk, MS Freag, SK Khiste, JY Fang, KA Elkhodairy, ... European Journal of Pharmaceutics and Biopharmaceutics 133, 42-62, 2018 | 46 | 2018 |
| Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells GA Patwardhan, SB Hosain, DX Liu, SK Khiste, Y Zhao, J Bielawski, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2014 | 30 | 2014 |
| Adsorption, equilibrium isotherm, and thermodynamic studies towards the removal of reactive orange 16 dye using Cu (I)-polyaninile composite PK Obulapuram, T Arfin, F Mohammad, SK Khiste, M Chavali, ... Polymers 13 (20), 3490, 2021 | 28 | 2021 |
| Drug release profiles of mitomycin c encapsulated quantum dots–chitosan nanocarrier system for the possible treatment of non-muscle invasive bladder cancer FAA Manan, NA Yusof, J Abdullah, F Mohammad, A Nurdin, LS Yazan, ... Pharmaceutics 13 (9), 1379, 2021 | 23 | 2021 |
| Ceramide–rubusoside nanomicelles, a potential therapeutic approach to target cancers carrying p53 missense mutations SK Khiste, Z Liu, KR Roy, MB Uddin, SB Hosain, X Gu, S Nazzal, RA Hill, ... Molecular cancer therapeutics 19 (2), 564-574, 2020 | 21 | 2020 |
| Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer T Saha, J Mondal, S Khiste, H Lusic, ZW Hu, R Jayabalan, KJ Hodgetts, ... Nanophotonics 10 (12), 3063-3073, 2021 | 18 | 2021 |
| Surface-enhanced biocompatibility and adsorption capacity of a zirconium phosphate-coated polyaniline composite PK Obulapuram, T Arfin, F Mohammad, K Kumari, SK Khiste, ... ACS omega 6 (49), 33614-33626, 2021 | 16 | 2021 |
| Investigation of the tribological characteristics of aluminum 6061-reinforced titanium carbide metal matrix composites GB Veeresh Kumar, R Pramod, R Hari Kiran Reddy, P Ramu, ... Nanomaterials 11 (11), 3039, 2021 | 15 | 2021 |
| Rubusoside-assisted solubilization of poorly soluble C6-Ceramide for a pilot pharmacokinetic study J Chen, SK Khiste, X Fu, KR Roy, Y Dong, J Zhang, M Liu, YY Liu, Z Liu Prostaglandins & Other Lipid Mediators 146, 106402, 2020 | 12 | 2020 |
| Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo SK Khiste, SB Hosain, Y Dong, MB Uddin, KR Roy, RA Hill, Z Liu, YY Liu Scientific Reports 7 (1), 2976, 2017 | 12 | 2017 |
| Aptasensor for the Detection of Mycobacterium tuberculosis in Sputum Utilising CFP10-ESAT6 Protein as a Selective Biomarker UZM Azmi, NA Yusof, J Abdullah, F Mohammad, SAA Ahmad, S Suraiya, ... Nanomaterials 11 (9), 2446, 2021 | 11 | 2021 |
| Nanoengineered disruption of heat shock protein 90 targets drug-induced resistance and relieves natural killer cell suppression in breast cancer M Smalley, SK Natarajan, J Mondal, D Best, D Goldman, B Shanthappa, ... Cancer research 80 (23), 5355-5366, 2020 | 11 | 2020 |
| Formulation and Optimization of Mouth dissolving tablets of Olanzapine by using 32 Factorial Design. DS Nandare, SK Mandlik, SK Khiste, YD Mohite Research Journal of Pharmacy and Technology 4 (8), 1265-1268, 2011 | 11 | 2011 |
| A Validated reverse phase HPLC method for simultaneous determination of telmisartan and ramipril as bulk drug and in tablet dosage form SV Gandhi, PB Deshpande, V Godbole, P Jagdale, S Khiste, S Kadukar Journal of Chemical, Biological and Physical Sciences (JCBPS) 1 (2), 283, 2011 | 3 | 2011 |
| Fluorescence HPLC Analysis of the in-vivo Activity of Glucosylceramide Synthase KR Roy, SK Khiste, Z Liu, YY Liu Bio-protocol 9 (12), e3269-e3269, 2019 | 2 | 2019 |
